HoneyNaps, specializing in AI-powered sleep medical devices, has developed a next-generation wireless polysomnography system that combines patch-based skin sensors with artificial intelligence-driven analysis. Polysomnography (PSG) is the standard diagnostic test for sleep disorders such as sleep apnea. Conventional PSG, however, generally requires patients to spend a night at a hospital […]
Tag: SpO2
ProSomnus Receives FDA Class II Clearance for RPMO₂ OSA Device
ProSomnus Sleep Technologies announced that the U.S. Food and Drug Administration (FDA) has granted Class II 510(k) clearance for its RPMO₂ OSA Device under the product codes DQA, LQZ, LRK, PLC, and OUG (FDA K252765). The RPMO2 OSA Device is the first theragnostic device for sleep medicine, incorporating both precision […]
Belun Introduces New Features & Innovations in Sleep Monitoring
Belun is excited to share some important updates to the Belun Sleep Platform, designed to bring more insights and improved interface for clinicians and researchers in sleep medicine. The latest update introduces trend-plotting capability for patient data, allowing you to: Track longitudinal changes in sleep and physiological data; Visualize patient treatment progress over time; Support clinical decision-making […]
ProSomnus Announces Significant Progress on Strategic Programs
ProSomnus Sleep Technologies announced significant progress on strategic programs. The key feature is the successful FDA registration of the company’s HWO2 buccal mucosal wellness oximeter. The ProSomnus HWO2 Device enables patients to monitor their nightly health and wellness during sleep, specifically, blood oxygen saturation, pulse rate and overall use time, […]
Masimo Announces Sleep Halo, Advanced Sleep Analysis for Masimo W1 Watch
Masimo has announced a groundbreaking update to its advanced health-tracking wearable, the Masimo W1® Sport. The new feature, Sleep Halo™, offers scientifically based sleep analysis, setting a new standard in sleep tracking technology. Unmatched Sleep Data Tracking and Comprehensive Sleep Insights Sleep Halo™ delivers unparalleled overnight sleep data tracking, recording […]
Masimo Enters the Consumer Wearables Market with Continuous SpO2
Masimo marks its 33rd anniversary by announcing the limited market release of the W1™ health watch for consumers. The first of its kind, the Masimo W1 offers accurate, continuous measurements and actionable health insights – from the leader in hospital pulse oximetry – in a personal, discreet, lifestyle-friendly wrist-worn wearable. […]
SpO2 Coming to Earbuds, Patches, and Other Wearable Devices
ams, a worldwide supplier of high-performance sensor solutions, introduced the industry’s thinnest dedicated sensor for blood oxygen saturation (SpO2) measurement, bringing the capability to remotely monitor this vital sign to small consumer products such as earbuds, smartwatches and wristbands, as well as to medical devices such as patches and oximeters. […]
Masimo Highly Accurate in Pediatric Respiratory Rate Study
Masimo announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp® on pediatric patients with the Rad-G™ Pulse Oximeter by comparing it to clinician-determined values while performing routine assessment of children admitted to outpatient and emergency departments.1 RRp provides respiration rate […]
Masimo Receives FDA Clearance of Continuous RRp Monitoring
Masimo announced that continuous RRp® (respiration rate from the photoplethysmograph) monitoring of adult and pediatric patients with Rad-97®, Radical-7®, and Radius-7® Pulse CO-Oximeters® has received FDA clearance. With this clearance, both continuous and spot-check RRp are now available in the US, supported in a variety of pulse oximetry sensors and configurations, including the […]
FDA Clears Second Generation Wireless Monitoring Platform
Murata Vios, Inc., a medical technology company that develops wireless patient-monitoring sensors and software, announced that it has received U.S. Food and Drug Administration (FDA) clearance for two 510(k) submissions for its second-generation wireless patient monitoring platform, the Vios Monitoring System (VMS). The approved suite of products provides a platform […]













